Skip to main content
. 2010 Feb 17;2010(2):CD006343. doi: 10.1002/14651858.CD006343.pub2

5.8. Analysis.

5.8

Comparison 5 All children: echinocandin versus lipid preparation of amphotericin B, Outcome 8 Any clinically significant adverse reactions attributed to the antifungal agent resulting in discontinuation, dose reduction or change in therapy.